These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1839286)

  • 21. Effects of dietary fatty acids, prostaglandins and related compounds on the role of platelets in thrombosis.
    Srivastava KC
    Biochem Exp Biol; 1980; 16(3):317-38. PubMed ID: 6268128
    [No Abstract]   [Full Text] [Related]  

  • 22. Dietary eicosapentaenoic acid and docosahexaenoic acid equally incorporate as decosahexaenoic acid but differ in inflammatory effects.
    Sierra S; Lara-Villoslada F; Comalada M; Olivares M; Xaus J
    Nutrition; 2008 Mar; 24(3):245-54. PubMed ID: 18312787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of n-3 polyunsaturated fatty acid on coronary heart disease].
    Lu G
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Oct; 18(5):279-81. PubMed ID: 2150806
    [No Abstract]   [Full Text] [Related]  

  • 24. [The influence of fat diet on plasma lipids and lipoproteins and platelet function].
    Furman B; Brook G; Nassara H; Aviram M
    Harefuah; 1986 Feb; 110(3):138-42. PubMed ID: 3519385
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet inhibitory functions of aortic endothelial cells. Effects of eicosapentaenoic and docosahexaenoic acids.
    Bénistant C; Achard F; Marcelon G; Lagarde M
    Atherosclerosis; 1993 Dec; 104(1-2):27-35. PubMed ID: 8141848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of the chronic internal administration of the new Russian n-3 polyunsaturated fatty acid concentrate--epaden--on blood coagulation system indices in rabbits].
    Petrukhina GN; Makarov VA; Kalugin SA; Gandel' VG
    Eksp Klin Farmakol; 1997; 60(2):37-41. PubMed ID: 9206567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What can we expect from omega-3 fatty acids?
    Chan EJ; Cho L
    Cleve Clin J Med; 2009 Apr; 76(4):245-51. PubMed ID: 19339640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of omega-3 fatty acids in men and women.
    Mueller BA; Talbert BL; Tegeler CH
    Clin Pharm; 1989 May; 8(5):328-9. PubMed ID: 2545407
    [No Abstract]   [Full Text] [Related]  

  • 29. Is docosahexaenoic acid more effective than eicosapentaenoic acid for increasing calcium bioavailability?
    Kruger MC; Schollum LM
    Prostaglandins Leukot Essent Fatty Acids; 2005 Nov; 73(5):327-34. PubMed ID: 16154334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eskimo plasma constituents, dihomo-gamma-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid inhibit the release of atherogenic mitogens.
    Smith DL; Willis AL; Nguyen N; Conner D; Zahedi S; Fulks J
    Lipids; 1989 Jan; 24(1):70-5. PubMed ID: 2545997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Essential polyunsaturated fatty acids].
    Asensio-Sánchez VM
    Arch Soc Esp Oftalmol; 2011 Apr; 86(4):124. PubMed ID: 21569923
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo modeling of docosahexaenoic acid and eicosapentaenoic acid-mediated inhibition of both platelet function and accumulation in arterial thrombi.
    Adili R; Voigt EM; Bormann JL; Foss KN; Hurley LJ; Meyer ES; Veldman AJ; Mast KA; West JL; Whiteheart SW; Holinstat M; Larson MK
    Platelets; 2019; 30(2):271-279. PubMed ID: 29286871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of atherogenesis by n-3 fatty acids in the cholesterol-fed rabbit.
    Demiroglu C; Ozder A; Altug T; Orbay B; Satar-Yíldírím S; Bilir A; Deniz G; Erbengi T; Büyükdevrim S
    Angiology; 1991 Apr; 42(4):323-30. PubMed ID: 1826589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial.
    Christensen JH; Gustenhoff P; Korup E; Aarøe J; Toft E; Møller J; Rasmussen K; Dyerberg J; Schmidt EB
    BMJ; 1996 Mar; 312(7032):677-8. PubMed ID: 8597736
    [No Abstract]   [Full Text] [Related]  

  • 35. Trans n-3 eicosapentaenoic and docosahexaenoic acid isomers exhibit different inhibitory effects on arachidonic acid metabolism in human platelets compared to the respective cis fatty acids.
    O'Keefe SF; Lagarde M; Grandgirard A; Sebedio JL
    J Lipid Res; 1990 Jul; 31(7):1241-6. PubMed ID: 2144870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EPA and/or DHA? A test question on the principles and opportunities in utilizing the therapeutic potential of omega-3 fatty acids.
    Schunck WH
    J Lipid Res; 2016 Sep; 57(9):1608-11. PubMed ID: 27436589
    [No Abstract]   [Full Text] [Related]  

  • 37. [The experimental and clinical aspects of eicosapentaenoic amd docosahexaenoic acids (a review of the literature and the author's own data)].
    Serhiienko OO
    Lik Sprava; 1995; (5-6):61-6. PubMed ID: 8630815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EPA and DHA possess different metabolic properties.
    Madsen L; Dyrøy E; Berge R
    Adv Exp Med Biol; 1999; 466():315-20. PubMed ID: 10709658
    [No Abstract]   [Full Text] [Related]  

  • 39. Dietary manipulation of platelet function.
    Bachmair EM; Ostertag LM; Zhang X; de Roos B
    Pharmacol Ther; 2014 Nov; 144(2):97-113. PubMed ID: 24858060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis of atherosclerosis with marine omega-3 fatty acids. A comprehensive strategy.
    von Schacky C
    Ann Intern Med; 1987 Dec; 107(6):890-9. PubMed ID: 2825573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.